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Abstract
Substantial evidences suggest that type 2 diabetes (T2DM) is a multi-factorial disease
with a strong genetic component. A list of genetic susceptibility loci in populations of
European and Asian ancestry has been established in the literature. Little is known on
the inter-ethnic contribution of such established functional polymorphic variants. We
performed a case-control study to explore the genetic susceptibility of 16 selected
T2DM related SNPs in a cohort of 102 Uyghur objects (51 cases and 51 controls).
Three of the 16 SNPs showed significant association with T2DM in the Uyghur
population. There were significant differences between the T2DM and control groups
in frequencies of the risk allelic distributions of rs7754840 (CDKAL1) (P=0.014),
rs864745 (JAZF1) (P=0.032) and rs35767 (IGF1) (P=0.044). Carriers of rs7754840-C,
rs35767-A and rs864745-C risk alleles had a 2.32-fold [OR (95% CI): 1.19-4.54],
2.06-fold [OR (95% CI): 1.02-4.17], 0.48-fold [OR (95% CI): 0.24-0.94] increased
risk for T2DM respectively. The cumulative risk allelic scores of these 16 SNPs
differed significantly between the T2DM patients and the controls [17.1±8.1 vs.
15.4±7.3; OR (95%CI): 1.27(1.07-1.50), P=0.007]. This is the first study to evaluate
genomic variation at 16 SNPs in respective T2DM candidate genes for the Uyghur
population compared with other ethnic groups The SNP rs7754840 in CDKAL1,
rs864745 in JAZF1 and rs35767 in IGF1 might serve as potential susceptibility loci
for T2DM in Uyghurs. We suggest a broader capture and study of the world
populations, including those that are hitherto understudied, are essential for a
comprehensive

understanding

of

the
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genetic/genomic

basis

of

T2DM.

Introduction
Type 2 diabetes mellitus (T2DM) is a complex disease characterized by insulin
resistance in peripheral tissues and dysregulated insulin secretion by pancreatic
beta-cells (Banerjee et al., 2014). Substantial evidences suggest that T2DM is a
multi-factorial disease with a strong genetic component. High concordance rate
obtained in monozygotic twins (96%) supports a substantial contribution of genetic
factors to T2DM (Barnett et al., 1981; Newman et al., 1987). Furthermore, 40% of
first-degree relatives of T2DM patients develop diabetes as compared to 6% in the
general population (KoÈbberling and Tillil, 1982). The general estimates of
heritability (h2) of T2DM is 0.49 and the relative recurrence risk for a sib of an
affected person (λs) to develop T2DM is 3.5 (Risch, 1990; Lander and Schork, 1994).
Multiple genetic loci have been discovered as risk factors for T2DM, most of which
were detected from genome-wide association studies (GWAS) in populations of
European and Asian ancestry (Sladek et al., 2007; Scott et al., 2007; Zeggini et al.,
2008; Ahlqvist et al., 2011; Saxena et al., 2007; Zeggini et al., 2008), e.g., loci near
cyclin-dependent kinase 5 (CDK5), regulatory subunit-associated protein 1-like 1
(CDKAL1) ( Saxena et al., 2007), peroxisome proliferator-activated receptor gamma
(PPARG) (Saxena et al., 2007) and juxtaposed with another zinc finger 1 (JAZF1)
( Zeggini et al., 2008). Most of these loci are related to insulin secretion and beta-cell
function, while a few are involved in insulin resistance (Ahlqvist et al., 2011; Billings
and Florez, 2010). To date, more than 40 genetic loci have been reported and
reproduced to be associated with T2DM or glycemic traits in Caucasian and Asian
6

populations (Ahlqvist et al., 2011).
There are differences in the contribution of known SNPs in T2DM susceptibility
genes among various ethnic populations (Klimentidis et al., 2011). SNP rs7754840 in
CDKAL1, identified as T2DM susceptibility locus in subjects from Finland and
Sweden by GWAS (Saxena et al., 2007) was replicated in Korean (Lee et al., 2008),
Han Chinese (Hu et al., 2009), Pima Indians (Rong et al., 2009) and Lebanese Arab
(Nemr et al., 2012), but showed inconsistent in risk allele frequencies and odds ratios
(ORs) among these ethnic populations. SNP rs864745 in JAZF1 was associated with
T2DM in European population (Zeggini et al., 2008), whereas it was not found to be
associated with T2DM in Chinese (Hu et al., 2009). Therefore, studies in other ethnic
populations could aid in determining population-specific risk variants for T2DM.
Uyghur population, settled in Xinjiang Uyghur autonomous region, northwestern
frontier area of China, accounts for 46% of the population in Xinjiang (Han Chinese
accounts for 40% and Kazak accounts for 7%). It is a population presenting a typical
admixture of Eastern and Western anthropometric traits (Wang et al., 2003; Black et
al., 2006). Uyghurs are overwhelmingly Muslim, and have their own language,
religious beliefs and lifestyles that are very different from either Han Chinese
population or American/European populations. Take dietary style as an example, the
Uyghur has a high dairy intake level (over 200g) with more flour and meat, and less
bean, vegetable and fishery products compared with Han Chinese living in the same
area (Zhai et al., 2007).
The prevalence of diabetes in Uyghur was higher than other ethnic groups in Xinjiang.
7

Tao et al reported that the prevalence of T2DM was 8.16% in Uyghur, which was
higher than 1.47% in Kazak population (Tao et al., 2008). Awuti et al reported that the
prevalence of T2DM for Uyghur adults was 9.5% (Awuti et al., 2012). In addition, a
cross-sectional study in Xinjiang found that 19.6% of Uyghur had diabetes,
exceptionally higher than that in Han Chinese (9.1%) and Kazakh (7.3%) (Li et al.,
2012). 6.23% of the Uyghur adults over 35 years old had diabetes, while 3.65% of
Kazak adults had diabetes (Yang et al., 2012). For children under 17 years old, 0.77%
of the Uyghur suffered from impaired fasting glucose (IFG) and diabetes, and that
was 0.1% in Kazak (Zhang et al., 2012).
Up to date, there have been only two reports on association of genetics makers with
T2DM in Uyghur. The G allele of adiponectin gene carriers with reduced plasma
concentrations of adiponectin might be associated with insulin resistance in Uyghur
(Li

et

al.,

2007).

In

addition,

peroxisome

proliferator-activated

receptor

(PPAR)-gamma Pro12Ala polymorphism might affect susceptibility to diabetes in
Uyghur (Li et al., 2008).
In this case-control study, we investigated the associations between 16 SNPs
susceptibility loci and T2DM as well as the combined effects of the SNPs on the risk
of T2DM in a Uyghur population.

Materials and Methods
Participants
A sample of 102 Uyghur participants was recruited from Uyghur population at Hetian
8

of Xinjiang, China, where Uyghur population was less affected by the recent
migration of Han Chinese. Fifty one T2DM patients (25 men and 26 women, age:
54.1±7.9 years old) were recruited from the local hospital as the T2DM group. The
control group without diabetes was comprised of 51 health check-up participants (23
men and 28 women, age: 55.9±9.9 years old).
Inclusion criteria for the T2DM group were: Participants were included if they 1) had
the ability to provide written informed consent, 2) were aged more than 18 years,
self-reported Uyghur ethnicity without intermarriage history with other ethnic groups
within the latest three generations, 3) were diagnosed with diabetes by physicians
according to 1999 World Health Organization (WHO) Criteria (fasting plasma glucose
greater than or equal to 7.0mmol/l and/ or 2-h plasma glucose greater than or equal to
11.1mmol/l) (Alberti et al., 1998), and 4) were diagnosis of T2DM from clinical
records obtained from the patients’ health care provider.
Inclusion criteria for the control group were: Participants were included if they 1) had
the ability to provide written informed consent, 2) were aged more than 18 years,
self-reported Uyghur ethnicity without intermarriage history with other ethnic groups
within the latest three generations, 3) did not have a documented clinical diagnosis of
diabetes or other metabolic diseases, and 4) were not taking glucose-lowering
medications and had fasting and 2h glucose values below the diagnostic thresholds for
diabetes.
Anthropometric measurements including weight, height and waist measurements were
obtained using standardized techniques. The body mass index (BMI) was calculated
9

by the formula weight (in kilograms)/height (in square meters). Systolic blood
pressure (SBP) and diastolic blood pressure (DBP) were measured with mercury
sphygmomanometer. Peripheral blood samples of patients and controls were collected
in EDTA-anti-coagulated tubes after an overnight fast. Plasma glucose concentrations
were measured by the glucose oxidase-peroxidase method using commercial kits.
Serum total cholesterol, serum triglycerides, high-density lipoprotein cholesterol
(HDL), Low-density lipoprotein cholesterol (LDL) and HbA1c were measured using
standard methods (cholesterol oxidase-peroxidase-amidopyrine method, glycerol
phosphate oxidase-peroxidase-amidopyrine method, enzymatic methods on a Hitachi
911 automated analyzer (Boehringer Mannheim, Mannheim, Germany), calculating
by

the

Friedewald

formula

and

determined

by

high-performance

liquid

chromatography, respectively).
The study was approved by the local community leaders and the ethics committee of
the Capital Medical University, Beijing, China.

Selection of the candidate SNPs and genotyping
Sixteen SNPs (rs1801282 (PPARG), rs7754840 (CDKAL1), rs10811661 (CDKN2A/B),
rs13266634 (SLC30A8), rs4402960 (IGF2BP2), rs7903146 (TCF7L2), rs10885122
(ADRA2A), rs174550 (FADS1), rs2191349 (DGKB), rs35767 (IGF1), rs12779790
(CDC123/CAMK1D), rs7961581 (TSPAN8), rs864745 (JAZF1), rs7578326 (IRS1),
rs780094 (GCKR) and rs4607517 (GCK)) were selected for the following reasons.
Firstly, minor allele frequencies (MAF) of these selected SNPs were more than 0.05
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in both HapMap CEU data and HapMap CHB data (http://hapmap.ncbi.nlm.nih.gov/).
These SNPs were reported to be associated with T2DM in several GWAS results
among European ancestry (Saxena et al., 2007; Zeggini et al., 2008; Voight et al.,
2010; Dupuis et al., 2010), while 13 of them (except for rs7578326 (IRS1), rs780094
(GCKR) and rs4607517 (GCK)) were also evaluated in Han Chinese population (Hu
et al., 2009; Wen et al., 2010; Liu et al., 2011; Hu et al., 2010; Zhou et al., 2010). IRS1,
GCKR and GCK were selected based on their roles in insulin signaling pathway
(Kyoto

Encyclopedia

of

http://www.genome.jp/kegg/kegg2.html).

Genes
Genomic

and
DNA was

Genomes:
extracted

from

whole-blood samples using QIAamp DNA Blood Mini Kit (Qiagen, German)
according to the manual instructions. Genomic DNA samples were subsequently
diluted to 25ng/μl. SNPs were genotyped using Mass ARRAY system (Sequenom,
Inc., SanDiego, CA).

Statistical analyses
Analyses were conducted in SPSS for WINDOWS version 18.0 (SPSS, Chicago, IL,
USA). Hardy-Weinberg equilibrium for genotype frequencies were tested by
Chi-square test. All continuous variables were expressed as the mean ± standard
deviation (SD). Continuous variables between T2DM and control group were
compared by Student’s t-test. The differences in the frequencies of various alleles and
genotypes between T2DM patients and controls were performed by Chi-square test,
and Fisher’s exact test was applied to the loci with a small number of alleles or
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genotypes (equal to or less than 5). Associations between SNPs and T2DM risks were
assessed using odds ratios (ORs) with 95% confidence intervals (95% CIs) and P
value derived from logistic regression adjusted for age and body mass index (BMI).
In addition, to evaluate the combined effects of the SNPs, cumulative scores of risk
alleles were counted. Risk allele was defined as OR>1 based on the results of
association analysis of candidate SNPs for T2DM. We considered an additive genetic
model for each SNP, and assigned a score of 0, 1, or 2 to genotypes at the 16 loci,
depending on whether subjects carried the wild-type allele or were heterozygous or
homozygous for the risk allele. The count method assumed that each risk allele
contributes equally and independently to the risk for T2DM. Association of
cumulative risk allelic scores and T2DM were also assessed using ORs with 95% CIs
and P value derived from logistic regression. The significant level was set at P < 0.05,
and all the analysis was two-sided.

Results
Sample characteristics
Participants’ characteristics are shown in Table 1. The BMI and HbAlc were
significantly higher in T2DM patients than those in control (25.0±0.4 vs. 23.3±0.3,
P=0.002; 7.3±2.1 vs. 5.1±0.7, P<0.001, respectively). The SBP, DBP, total cholesterol,
triacylglycerol and glucose were also higher in T2DM patients than in control group
(135.9±1.8 vs. 124.0±1.5, P<0.001; 87.8±1.4 vs. 81.8±1.1, P=0.001; 4.9±0.1 vs.
4.4±0.1, P=0.020; 2.2±0.1 vs. 1.7±0.1, P=0.006, 9.1±0.4 vs. 5.3±0.1, P<0.001,
12

respectively).
Association analysis of candidate SNPs for T2DM
Sixteen SNPs from known T2DM susceptibility loci were genotyped in 102 Uyghur
participants. The genotype call rate for each SNP was > 95%. There are two major
causes for the missing calls. One is due to poor quality of DNA samples, which often
fails to be amplified and to generate strong enough intensity of fluorescence signals
over the background. The other arises when an observation, i.e., a read out of
fluorescence signals, cannot be assigned unequivocally to any of the clusters of
genotype, and, therefore, is subject to 'no-call' procedure. In this report, the missing
calls are mainly due to the poor quality of DNA samples. Allelic frequencies of these
16 SNPs were shown in Table 2. The distributions of allelic frequencies of the 15
SNPs were all in Hardy-Weinberg equilibrium (HWE) in both cases and controls
(P>0.05), except that of the rs4402960 (P=0.05) in the T2DM cases. The minor allele
frequencies (MAF) of these SNPs were ranging from 0.10 to 0.46.
Allelic frequencies of three SNPs (rs7754840 (CDKAL1), rs864745 (JAZF1) and
rs35767 (IGF1)) were significant different between the T2DM and control group
(P<0.05). For rs7754840 (CDKAL1), frequencies of the C and G alleles were 0.24 and
0.76, respectively in control group. Frequencies of the C allele were significantly
higher in T2DM patients than that in control group (0.46 vs. 0.24, P=0.005). For
rs864745 (JAZF1), frequencies of the C and T alleles were 0.42 and 0.58 in control
group. Frequency of the T allele was significantly higher in T2DM patients than that
in control group (0.71 vs. 0.58, P=0.049). For rs35767 (IGF1), frequencies of the A
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and G alleles were 0.21 and 0.79 in control group. Frequency of the G allele was
significantly lower in T2DM patients than that in control group (0.67 vs. 0.79,
P=0.033). Logistic regression analysis (adjusted for age and BMI) revealed that
participants with the C allele for rs7754840 (CDKAL1) had a 2.32-fold [OR (95%CI):
1.19-4.54, P=0.014] risk of T2DM compared with the G allele. SNP rs864745 (JAZF1)
and SNP rs35767 (IGF1) were also found to be significantly associated with T2DM in
logistic regression analysis [OR (95% CI): 0.48 (0.24-0.94), P=0.032 vs. OR (95%
CI): 2.06 (1.02-4.17), P=0.044] (Table 2). Contrary to SNP rs35767/GG, SNPs
rs7754840/CC and rs864745/TT were more frequent in the diabetes group compared
to the control group (42% vs 66.7%; 21.6% vs 5.9%; 49% vs 39.2%, respectively;
Table 3).
To evaluate the combined effects of these 16 SNPs, we calculated the cumulative risk
allelic scores of these 16 risk alleles that each participant had. The average of
cumulative risk allelic scores of T2DM patients and control group were 17.1±8.1 and
15.4±7.3 (P=0.002, t-test), respectively. The risk allelic scores were associated with
T2DM in logistic regression analysis adjusted with age and BMI (OR: 1.27, 95% CI:
1.07-1.50, P=0.007).

Discussion
Variants in more than 40 loci were identified to be associated with T2DM in more
than one population by GWAS results. Some variants were associated with T2DM in
one ethnic group of subjects but not in others. SNPs in PPARG, CDKAL1, CDKN2A/B,
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SLC30A8, IGF2BP2, TCF7L2, ADRA2A, FADS1, DGKB, IGF1, CDC123/CAMK1D,
TSPAN8 and JAZF1 were identified to be associated with T2DM in European
population by GWAS (Saxena et al.,2007; Zeggini et al., 2008; Dupuis et al., 2010).
These SNPs have been confirmed by multiple studies in various populations, such as
Danes, Han Chinese and Japanese (Hu et al., 2009;Wen et al., 2010; Liu et al., 2011;
Hu et al., 2010; Zhou et al., 2010; Grarup et al., 2008; Ohshige et al., 2011).

Study findings
In this study, the associations of SNPs in 16 respective T2DM candidate genes were
investigated in Uyghurs. The Uyghur participants were recruited from Uyghur
population at Hetian of Xinjiang, China, where the Uyghur population is less affected
by the recent migration of Han Chinese and keeps its traditional lifestyles for
generations, with its own language, religious beliefs and marriage pattern (Black et al.,
2006). Therefore, the Uyghur would be an ideal population for the study of evaluating
genetic susceptibility. To our knowledge, this was the first attempt that a cohort of
SNPs in PPARG, CDKAL1, CDKN2A/B, SLC30A8, IGF2BP2, TCF7L2, ADRA2A,
FADS1, DGKB, IGF1, CDC123/CAMK1D, TSPAN8, JAZF1, IRS1, GCKR and GCK
were genotyped in Uyghur participants for T2DM susceptibility study.
CDKAL1 is one of the most significant diabetes susceptibility genes identified to date
in various populations. Intronic CDKAL1 variants rs7754840 has been found to be
associated with T2DM mainly due to impaired first-phase insulin release (Chistiakov
et al., 2011; Stancakova et al., 2008). SNPs rs7756992, rs10946398 and rs9465871 in
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CDKAL1 were also found to be associated with T2DM among European population,
Pima Indian, Han Chinese and Korean population in previous studies (Lee et al., 2008;
Hu et al., 2009; Rong et al., 2009; Steinthorsdottir et al., 2007; Dehwah et al., 2010).
Our study has revealed that the C allele of rs7754840 of CDKAL1 was significantly
associated with T2DM in Uyghur participants (P=0.014, adjusted for age and BMI).
The OR value of rs7754840 was 2.32, higher than that of Han Chinese (1.127) (Hu et
al., 2009), Pima Indians (1.06) (Rong et al., 2009) and Lebanese Arab population
(1.86) (Nemr et al., 2012). T2DM patients had a higher CC genotype and lower GG
genotype of CDKAL1 when compared with the control group (Chi-square: 17.448, P
<0.001, Table 3). This result was compatible with a study among Korean population,
in which the CC genotype was significant higher in T2DM patients than that in
controls (Lee et al., 2008).
Among the other loci examined in this study, SNP rs864745 in JAZF1 also showed
the most significant association with T2DM in Uyghur (P=0.032, adjusted for age and
BMI). SNP rs864745 resides in intron-1 of JAZF1 gene, encoding a transcriptional
repressor of the nuclear receptor subfamily-2, group C, member-2 (NR2C2) gene
(Nakajima et al., 2004). The carriage of JAZF1 risk variants may lead to postnatal
growth restriction mainly due to affecting pancreatic β-cell mass and function (Grarup
et al., 2008). The association between rs864745 and T2DM varied among populations.
SNP rs864745 was strongly associated with T2DM in European participants (P=
5.0×10-14) (Zeggini et al., 2008), whereas no significant association was observed in
Han Chinese (P>0.05) (Hu et al., 2009) and Japanese subjects (P>0.05) (Takeuchi et
16

al., 2009). In our study, the OR value of rs864745 (0.48) was lower than that in
Caucasians (1.50) (An et al., 2009), Han Chinese population (1.05-1.09) (Hu et al.,
2009; Zhou et al., 2010) and Pakistani population (1.16) (Rees et al., 2011).
Frequency of the CC genotype of rs864745 (JAZF1) was lower in T2DM patients
than that in control group (Table 3, 6.1% vs. 23.5%), indicating its protective effect on
T2DM in Uyghur participants.
The rs35767 polymorphism resides 1.2 kb upstream of IGF1 which is a biologically
plausible fasting insulin-raising gene. A previous study reported that the effects of the
rs35767 polymorphism near IGF1 on fasting insulin are mediated by reduced insulin
sensitivity or impaired insulin clearance; and those carriers of the GG genotype have
lower insulin sensitivity as compared with subjects carrying the A allele in white
Europeans (Mannino et al., 2013). The finding that the G allele of rs35767 (IGF1)
was associated with fasting insulin and HOMA-IR in European population (Dupuis et
al., 2010) as well as in Han Chinese (Hu et al., 2010) is not new. In our study, there
was significant difference in the frequency of G allele for rs35767 (IGF1) between
T2DM patients and controls (P=0.033). T2DM patients had a lower frequency of GG
genotype (42.0% vs. 66.7%) compared to that of control group. The unique life style
and marriage pattern might be responsible for such an observation. Most Uyghurs live
as farmers, and have different dietary habits with Han Chinese. They have high
carbon hydrate dietary with a higher salt (more than 20g per day), more meat and less
unsaturated fatty acids compared with Han Chinese (Zhai et al., 2007). Then, the
practice of endogamy in Uyghur population might also be a reason (Wang et al., 2003;
17

Mamet et al., 2005).
The previous studies reported that accumulative number of risk alleles may be
associated with T2DM, even though these alleles were not observed to be statistically
significances individually (Fontaine-Bisson et al., 2010; Yamakawa-Kobayashi et al.,
2012). We calculated the cumulative risk allelic scores of these 16 risk alleles to
evaluate the combined effects of these 16 SNPs, and a significance association was
observed between accumulative risk allelic scores and T2DM in the Uyghur
population samples (P=0.007).

Study limitations
While this study provides valuable insight into the genetic difference of T2DM related
loci in minority groups, it has some limitations. Firstly, the ideal sample size should
be about 300 pairs for cases and controls when we initiated this study. No multiple
comparisons were attempted due to the relative small sample size than we originally
designed in this pilot study. The statistical power of rs7754840 was calculated to 95%
at the significance of 0.05, and those of other SNPs were less than 80% (SAS Proc
Power). Because the people of minority groups usually refuse to participate in some
investigation studies. Combined with less participant rate, the blood sampling is a
very hard practice in Xinjiang, a very remote area of the northwestern frontier part of
China. These are preliminary findings and further case-control studies with large
samples and multiple comparisons are warranted to provide a more definite
explanation about the relationships between those SNPs and T2DM based on our
18

observation. Secondly, the existence of the interaction between environmental factors
(e.g., life style, dietary, climates) and the T2DM susceptibility loci is needed to be
further validated in Uyghur population. Moreover, the important information on rare
variants with stronger effects on T2DM could be revealed by the next-generation of
whole genome sequencing when the technique routine could be available in not far
future.

Conclusions and Future Outlook
This is the first study to evaluate genomic variation at 16 SNPs in respective T2DM
candidate genes for the Uyghur population compared with other ethnic groups. The
SNP rs7754840 in CDKAL1, rs864745 in JAZF1 and rs35767 in IGF1 might serve as
potential susceptibility loci for T2DM in Uyghurs. We suggest that a broader capture
and study of the world populations, including those that are hitherto understudied or
overlooked, are necessary for a comprehensive understanding of the genetic/genomic
basis of T2DM. Additionally, plant OMICS research including those with traditional
plants (Sahu et al., 2014) that offer potential novel therapeutics for T2DM could be
usefully is combined with studies of T2DM genetics so as to inform future
personalized medicine research, global health and society.
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